By Josh White
Date: Monday 07 Oct 2024
LONDON (ShareCast) - (Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
The AIM-traded firm said the milestone followed the successful distribution of online pre-orders and the availability of Eroxon in US retail stores.
It said the payment was expected to be received shortly.
Eroxon, Futura's flagship product, is a clinically-proven sexual health product.
The milestone payment was another key step in its ongoing strategy to commercialise its products globally, with the US launch being a major milestone in the product's growth.
At 1356 BST, shares in Futura Medical were up 2.77% at 33.45p.
Reporting by Josh White for Sharecast.com.
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 413.90p |
Change Today | -1.30p |
% Change | -0.31 % |
52 Week High | 419.50 |
52 Week Low | 320.80 |
Volume | 80,249,496 |
Shares Issued | 9,002m |
Market Cap | £37,260m |
Beta | 0.00 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 24-Apr-25 | 15-Aug-24 |
Paid | 05-Jun-25 | 19-Sep-24 |
Amount | 4.60p | 2.00p |
Time | Volume / Share Price |
15:25 | 9,611,481 @ 416.60p |
15:25 | 9,611,481 @ 416.60p |
17:05 | 200,000 @ 415.25p |
16:47 | 103,872 @ 417.70p |
16:45 | 911 @ 413.90p |
You are here: research